TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

OMEPRAZOLE AND SODIUM BICARBONATE

OMEPRAZOLE
Approved 2010-05-25
Jump to: Indications Approvals Trials Competitors Safety Patents
12
Indications
--
Phase 3 Trials
15
Years on Market

Details

Status
Over-the-counter
First Approved
2010-05-25
Routes
ORAL
Dosage Forms
CAPSULE, FOR SUSPENSION

Companies

Aurobindo Pharma Dr. Reddy's STRIDES PHARMA INTL SCIEGEN PHARMS ANDA REPOSITORY NOVITIUM PHARMA AJANTA PHARMA LTD ZYDUS PHARMS AUROLIFE PHARMA LLC PERRIGO R AND D ZYDUS CHARTWELL RX
Active Ingredient: OMEPRAZOLE , SODIUM BICARBONATE

OMEPRAZOLE AND SODIUM BICARBONATE Approval History

Loading approval history...

What OMEPRAZOLE AND SODIUM BICARBONATE Treats

12 FDA approvals

Originally approved for its first indication in 2010 . Covers 12 distinct patient populations.

  • Other (12)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

OMEPRAZOLE AND SODIUM BICARBONATE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA204923 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.